- 大部份公司都有淡旺季, 所以通常是看年增率
- 如果是成長期(在炒新的成長動能)的公司或景氣從谷底翻揚, 就可以觀察月增率
- 漲很多的股票要留意營收年增率或月增率大幅減少, 又或者是合約負債已經開始減少
- 留意短期平均營收向上或向下穿越長期平均營收
- 觀察累計營收年增率的累計增加或虧損收斂
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/10 | 4.6 | 17.77 | 13.13 | 37.98 | 18.57 | 11.75 | N/A | - | ||
| 2024/9 | 3.91 | 20.88 | 24.96 | 33.37 | 19.36 | 11.31 | 1.7 | - | ||
| 2024/8 | 3.23 | -22.36 | 4.63 | 29.46 | 18.66 | 11.09 | 1.74 | - | ||
| 2024/7 | 4.16 | 12.7 | 33.22 | 26.23 | 20.65 | 11.8 | 1.63 | - | ||
| 2024/6 | 3.7 | -6.19 | 15.16 | 22.07 | 18.54 | 11.41 | 1.67 | - | ||
| 2024/5 | 3.94 | 4.41 | 24.99 | 18.37 | 19.24 | 11.69 | 1.63 | - | ||
| 2024/4 | 3.77 | -5.06 | 26.9 | 14.43 | 17.76 | 10.71 | 1.78 | - | ||
| 2024/3 | 3.97 | 34.02 | 5.35 | 10.66 | 14.84 | 10.66 | 1.72 | - | ||
| 2024/2 | 2.96 | -20.29 | 2.84 | 6.68 | 21.34 | 10.15 | 1.8 | - | ||
| 2024/1 | 3.72 | 7.34 | 41.64 | 3.72 | 41.64 | 10.99 | 1.66 | - | ||
| 2023/12 | 3.47 | -8.97 | 20.74 | 39.3 | 24.02 | 11.34 | 1.49 | - | ||
| 2023/11 | 3.81 | -6.42 | 16.11 | 35.83 | 24.34 | 11.0 | 1.54 | - | ||
| 2023/10 | 4.07 | 30.08 | 31.05 | 32.03 | 25.4 | 10.29 | 1.64 | - | ||
| 2023/9 | 3.13 | 1.22 | 1.21 | 27.96 | 24.62 | 9.34 | 1.74 | - | ||
| 2023/8 | 3.09 | -1.15 | 36.17 | 24.83 | 28.36 | 9.42 | 1.73 | - | ||
| 2023/7 | 3.13 | -2.57 | 50.01 | 21.74 | 27.32 | 9.49 | 1.72 | 主要係本月美國、日本及歐洲區域營收較去年同期增加。 | ||
| 2023/6 | 3.21 | 1.8 | 12.03 | 18.61 | 24.17 | 9.33 | 1.58 | - | ||
| 2023/5 | 3.15 | 6.0 | 34.68 | 15.41 | 27.04 | 9.9 | 1.49 | - | ||
| 2023/4 | 2.97 | -21.18 | 24.45 | 12.25 | 25.21 | 9.63 | 1.53 | - | ||
| 2023/3 | 3.77 | 30.83 | 29.22 | 9.28 | 25.46 | 9.28 | 1.46 | - | ||
| 2023/2 | 2.88 | 9.77 | 30.64 | 5.51 | 23.0 | 8.38 | 1.62 | - | ||
| 2023/1 | 2.63 | -8.5 | 15.59 | 2.63 | 15.59 | 8.78 | 1.54 | - | ||
| 2022/12 | 2.87 | -12.46 | 27.05 | 31.69 | 23.25 | 9.25 | 1.41 | - | ||
| 2022/11 | 3.28 | 5.61 | 32.92 | 28.82 | 22.88 | 9.47 | 1.37 | - | ||
| 2022/10 | 3.1 | 0.46 | 20.63 | 25.54 | 21.7 | 8.46 | 1.54 | - | ||
| 2022/9 | 3.09 | 36.17 | 42.4 | 22.43 | 21.85 | 7.44 | 1.68 | - | ||
| 2022/8 | 2.27 | 8.89 | 18.86 | 19.34 | 19.11 | 7.22 | 1.73 | - | ||
| 2022/7 | 2.08 | -27.23 | -1.14 | 17.07 | 19.14 | 7.29 | 1.71 | - | ||
| 2022/6 | 2.86 | 22.39 | 79.36 | 14.99 | 22.64 | 7.59 | 1.55 | 主要是去年110年6月疫情嚴重，今年111年各國疫情趨緩，故各區營收皆較去年同期增加，其中以中南美洲.歐洲及國內增加為主要。 | ||
| 2022/5 | 2.34 | -2.04 | 16.17 | 12.13 | 14.12 | 7.65 | 1.54 | - | ||
| 2022/4 | 2.39 | -18.16 | 1.78 | 9.79 | 13.64 | 7.51 | 1.56 | - | ||
| 2022/3 | 2.92 | 32.28 | 9.28 | 7.4 | 18.08 | 7.4 | 1.56 | - | ||
| 2022/2 | 2.21 | -2.87 | 38.48 | 4.48 | 24.61 | 6.74 | 1.71 | - | ||
| 2022/1 | 2.27 | 0.57 | 13.56 | 2.27 | 13.56 | 7.0 | 1.65 | - | ||
| 2021/12 | 2.26 | -8.42 | -7.33 | 25.71 | 9.76 | 7.3 | 1.51 | - | ||
| 2021/11 | 2.47 | -4.15 | 11.72 | 23.45 | 11.74 | 7.21 | 1.53 | - | ||
| 2021/10 | 2.57 | 18.59 | 20.25 | 20.98 | 11.75 | 6.65 | 1.66 | - | ||
| 2021/9 | 2.17 | 13.66 | 3.26 | 18.41 | 10.65 | 6.19 | 1.88 | - | ||
| 2021/8 | 1.91 | -9.43 | -8.79 | 16.24 | 11.72 | 5.61 | 2.07 | - | ||
| 2021/7 | 2.11 | 32.02 | -8.51 | 14.33 | 15.17 | 5.72 | 2.03 | - | ||
| 2021/6 | 1.6 | -20.72 | -16.87 | 12.22 | 20.56 | 5.96 | 1.94 | - | ||
| 2021/5 | 2.01 | -14.17 | 10.38 | 10.63 | 29.31 | 7.03 | 1.64 | - | ||
| 2021/4 | 2.35 | -12.12 | 102.21 | 8.61 | 34.71 | 6.61 | 1.75 | 係因去年台灣內銷市場、美國及歐洲子公司受COVID-19影響，致使109年4月較110年4月營收減少102.22% | ||
| 2021/3 | 2.67 | 67.61 | 53.54 | 6.26 | 19.74 | 6.26 | 1.82 | 係因去年台灣內銷市場、美國及歐洲子公司受COVID-19影響，致使109年3月較110年3月營收減少53.55% | ||
| 2021/2 | 1.59 | -20.34 | -20.32 | 3.59 | 2.9 | 6.03 | 1.89 | - | ||
| 2021/1 | 2.0 | -17.93 | 34.04 | 2.0 | 34.04 | 6.65 | 1.72 | - | ||
| 2020/12 | 2.44 | 10.41 | 10.0 | 23.42 | -3.87 | 6.79 | 1.66 | - | ||
| 2020/11 | 2.21 | 3.15 | 5.71 | 20.98 | -5.26 | 6.45 | 1.75 | - | ||
| 2020/10 | 2.14 | 1.84 | -0.66 | 18.78 | -6.4 | 6.33 | 1.78 | - | ||
| 2020/9 | 2.1 | 0.38 | 2.15 | 16.64 | -7.1 | 6.5 | 1.72 | - | ||
| 2020/8 | 2.09 | -9.15 | 27.2 | 14.54 | -8.3 | 6.32 | 1.77 | - | ||
| 2020/7 | 2.3 | 19.95 | 9.47 | 12.44 | -12.41 | 6.05 | 1.84 | - | ||
| 2020/6 | 1.92 | 5.27 | 10.27 | 10.14 | -16.22 | 4.91 | 2.32 | - | ||
| 2020/5 | 1.82 | 57.21 | -19.77 | 8.22 | -20.67 | 4.72 | 2.41 | - | ||
| 2020/4 | 1.16 | -33.27 | -52.55 | 6.39 | -20.92 | 4.9 | 2.32 | 因國內內銷、美國子公司及法國子公司受到新型冠狀病毒(COVID-19)影響，致使單月收入減少52.55%。 | ||
| 2020/3 | 1.74 | -13.02 | -10.33 | 5.23 | -7.21 | 5.23 | 2.24 | - | ||
| 2020/2 | 2.0 | 34.01 | 21.32 | 3.49 | -5.57 | 5.71 | 2.05 | - | ||
| 2020/1 | 1.49 | -32.65 | -27.2 | 1.49 | -27.2 | 5.8 | 2.02 | - | ||
| 2019/12 | 2.22 | 6.1 | 13.09 | 24.37 | 4.47 | 0.0 | N/A | - | ||
| 2019/11 | 2.09 | -3.06 | 2.15 | 22.15 | 3.68 | 0.0 | N/A | - |
| 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 | 年/月 | 營收 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/1 | 3.72 | 2023/1 | 2.63 | 2022/1 | 2.27 | 2021/1 | 2.0 | 2020/1 | 1.49 |
| 2024/2 | 2.96 | 2023/2 | 2.88 | 2022/2 | 2.21 | 2021/2 | 1.59 | 2020/2 | 2.0 |
| 2024/3 | 3.97 | 2023/3 | 3.77 | 2022/3 | 2.92 | 2021/3 | 2.67 | 2020/3 | 1.74 |
| 2024/4 | 3.77 | 2023/4 | 2.97 | 2022/4 | 2.39 | 2021/4 | 2.35 | 2020/4 | 1.16 |
| 2024/5 | 3.94 | 2023/5 | 3.15 | 2022/5 | 2.34 | 2021/5 | 2.01 | 2020/5 | 1.82 |
| 2024/6 | 3.7 | 2023/6 | 3.21 | 2022/6 | 2.86 | 2021/6 | 1.6 | 2020/6 | 1.92 |
| 2024/7 | 4.16 | 2023/7 | 3.13 | 2022/7 | 2.08 | 2021/7 | 2.11 | 2020/7 | 2.3 |
| 2024/8 | 3.23 | 2023/8 | 3.09 | 2022/8 | 2.27 | 2021/8 | 1.91 | 2020/8 | 2.09 |
| 2024/9 | 3.91 | 2023/9 | 3.13 | 2022/9 | 3.09 | 2021/9 | 2.17 | 2020/9 | 2.1 |
| 2024/10 | 4.6 | 2023/10 | 4.07 | 2022/10 | 3.1 | 2021/10 | 2.57 | 2020/10 | 2.14 |
| N/A | N/A | 2023/11 | 3.81 | 2022/11 | 3.28 | 2021/11 | 2.47 | 2020/11 | 2.21 |
| N/A | N/A | 2023/12 | 3.47 | 2022/12 | 2.87 | 2021/12 | 2.26 | 2020/12 | 2.44 |
- 每季的合約負債通常會反應在未來半年到一年後的營收
| 合約負債 QoQ YoY | |||
|---|---|---|---|
| 24Q3 (20) | 0.01 | -50.0 | -90.0 |
| 24Q2 (19) | 0.02 | -33.33 | -75.0 |
| 24Q1 (18) | 0.03 | -25.0 | -88.0 |
| 23Q4 (17) | 0.04 | -60.0 | -75.0 |
| 23Q3 (16) | 0.1 | 25.0 | -16.67 |
| 23Q2 (15) | 0.08 | -68.0 | 0.0 |
| 23Q1 (14) | 0.25 | 56.25 | 25.0 |
| 22Q4 (13) | 0.16 | 33.33 | 14.29 |
| 22Q3 (12) | 0.12 | 50.0 | -25.0 |
| 22Q2 (11) | 0.08 | -60.0 | -57.89 |
| 22Q1 (10) | 0.2 | 42.86 | 53.85 |
| 21Q4 (9) | 0.14 | -12.5 | 100.0 |
| 21Q3 (8) | 0.16 | -15.79 | 45.45 |
| 21Q2 (7) | 0.19 | 46.15 | 533.33 |
| 21Q1 (6) | 0.13 | 85.71 | 116.67 |
| 20Q4 (5) | 0.07 | -36.36 | 75.0 |
| 20Q3 (4) | 0.11 | 266.67 | 0.0 |
| 20Q2 (3) | 0.03 | -50.0 | 0.0 |
| 20Q1 (2) | 0.06 | 50.0 | 0.0 |
| 19Q4 (1) | 0.04 | 0.0 | 0.0 |
